Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study

Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study

Objective: To report on the efficacy of pembrolizumab, bevacizumab, and oral metronomic cyclophosphamide used in combination for patients with platinum resistant recurrent ovarian cancer in community practice. Methods: This retrospective observational study was conducted at a single gynecologic onco...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandra R. Steck, Barbara Mahar, Jovana Y. Martin, Timothy J. McElrath, Patrick F. Timmins, III, Joyce N. Barlin
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Gynecologic Oncology Reports
Subjects:
Platinum-resistant ovarian cancer
Epithelial ovarian cancer
Community-based cancer treatment
Immune checkpoint inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578925001183
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items